Recommendations from the national multiple sclerosis society clinical outcomes assessment task force

Richard Rudick, Jack Antel, Christian Confavreux, Gary Cutter, George Ellison, Jill Fischer, Fred Lublin, Aaron Miller, John Petkau, Stephen Rao, Stephen Reingold, Karl Syndulko, Alan Thompson, Joy Wallenberg, Brian G Weinshenker, Ernest Willoughby

Research output: Contribution to journalArticle

298 Citations (Scopus)

Abstract

This article provides recommendations from the National Multiple Sclerosis Society's Clinical Outcomes Assessment Task Force. The Task Force was appointed in 1994 and charged with recommendending improved approaches for clinical outcomes assessment in future controlled clinical trials. The recommendations herein follow extensive deliberation and data analysis during 2.5 years. General principles and desirable measurement attributes were used to assess alternative measurement techniques and clinical scales. On the basis of the analysis of existing multiple sclerosis (MS) data sets, a new measurement approach is proposed. The approach is based on quantitative functional composites that consist of simple quantitative measures from the major clinical dimensions of MS combined into a single score. Quantitative functional composites are likely to provide improved precision and sensitivity in future MS clinical trials. Studies necessary to further refine quantitative functional composites as useful MS clinical trial outcomes are delineated.

Original languageEnglish (US)
Pages (from-to)379-382
Number of pages4
JournalAnnals of Neurology
Volume42
Issue number3
StatePublished - 1997
Externally publishedYes

Fingerprint

Advisory Committees
Multiple Sclerosis
Outcome Assessment (Health Care)
Clinical Trials
Controlled Clinical Trials

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rudick, R., Antel, J., Confavreux, C., Cutter, G., Ellison, G., Fischer, J., ... Willoughby, E. (1997). Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. Annals of Neurology, 42(3), 379-382.

Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. / Rudick, Richard; Antel, Jack; Confavreux, Christian; Cutter, Gary; Ellison, George; Fischer, Jill; Lublin, Fred; Miller, Aaron; Petkau, John; Rao, Stephen; Reingold, Stephen; Syndulko, Karl; Thompson, Alan; Wallenberg, Joy; Weinshenker, Brian G; Willoughby, Ernest.

In: Annals of Neurology, Vol. 42, No. 3, 1997, p. 379-382.

Research output: Contribution to journalArticle

Rudick, R, Antel, J, Confavreux, C, Cutter, G, Ellison, G, Fischer, J, Lublin, F, Miller, A, Petkau, J, Rao, S, Reingold, S, Syndulko, K, Thompson, A, Wallenberg, J, Weinshenker, BG & Willoughby, E 1997, 'Recommendations from the national multiple sclerosis society clinical outcomes assessment task force', Annals of Neurology, vol. 42, no. 3, pp. 379-382.
Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J et al. Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. Annals of Neurology. 1997;42(3):379-382.
Rudick, Richard ; Antel, Jack ; Confavreux, Christian ; Cutter, Gary ; Ellison, George ; Fischer, Jill ; Lublin, Fred ; Miller, Aaron ; Petkau, John ; Rao, Stephen ; Reingold, Stephen ; Syndulko, Karl ; Thompson, Alan ; Wallenberg, Joy ; Weinshenker, Brian G ; Willoughby, Ernest. / Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. In: Annals of Neurology. 1997 ; Vol. 42, No. 3. pp. 379-382.
@article{64cd69039d424452be4dd99ee8d962ac,
title = "Recommendations from the national multiple sclerosis society clinical outcomes assessment task force",
abstract = "This article provides recommendations from the National Multiple Sclerosis Society's Clinical Outcomes Assessment Task Force. The Task Force was appointed in 1994 and charged with recommendending improved approaches for clinical outcomes assessment in future controlled clinical trials. The recommendations herein follow extensive deliberation and data analysis during 2.5 years. General principles and desirable measurement attributes were used to assess alternative measurement techniques and clinical scales. On the basis of the analysis of existing multiple sclerosis (MS) data sets, a new measurement approach is proposed. The approach is based on quantitative functional composites that consist of simple quantitative measures from the major clinical dimensions of MS combined into a single score. Quantitative functional composites are likely to provide improved precision and sensitivity in future MS clinical trials. Studies necessary to further refine quantitative functional composites as useful MS clinical trial outcomes are delineated.",
author = "Richard Rudick and Jack Antel and Christian Confavreux and Gary Cutter and George Ellison and Jill Fischer and Fred Lublin and Aaron Miller and John Petkau and Stephen Rao and Stephen Reingold and Karl Syndulko and Alan Thompson and Joy Wallenberg and Weinshenker, {Brian G} and Ernest Willoughby",
year = "1997",
language = "English (US)",
volume = "42",
pages = "379--382",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Recommendations from the national multiple sclerosis society clinical outcomes assessment task force

AU - Rudick, Richard

AU - Antel, Jack

AU - Confavreux, Christian

AU - Cutter, Gary

AU - Ellison, George

AU - Fischer, Jill

AU - Lublin, Fred

AU - Miller, Aaron

AU - Petkau, John

AU - Rao, Stephen

AU - Reingold, Stephen

AU - Syndulko, Karl

AU - Thompson, Alan

AU - Wallenberg, Joy

AU - Weinshenker, Brian G

AU - Willoughby, Ernest

PY - 1997

Y1 - 1997

N2 - This article provides recommendations from the National Multiple Sclerosis Society's Clinical Outcomes Assessment Task Force. The Task Force was appointed in 1994 and charged with recommendending improved approaches for clinical outcomes assessment in future controlled clinical trials. The recommendations herein follow extensive deliberation and data analysis during 2.5 years. General principles and desirable measurement attributes were used to assess alternative measurement techniques and clinical scales. On the basis of the analysis of existing multiple sclerosis (MS) data sets, a new measurement approach is proposed. The approach is based on quantitative functional composites that consist of simple quantitative measures from the major clinical dimensions of MS combined into a single score. Quantitative functional composites are likely to provide improved precision and sensitivity in future MS clinical trials. Studies necessary to further refine quantitative functional composites as useful MS clinical trial outcomes are delineated.

AB - This article provides recommendations from the National Multiple Sclerosis Society's Clinical Outcomes Assessment Task Force. The Task Force was appointed in 1994 and charged with recommendending improved approaches for clinical outcomes assessment in future controlled clinical trials. The recommendations herein follow extensive deliberation and data analysis during 2.5 years. General principles and desirable measurement attributes were used to assess alternative measurement techniques and clinical scales. On the basis of the analysis of existing multiple sclerosis (MS) data sets, a new measurement approach is proposed. The approach is based on quantitative functional composites that consist of simple quantitative measures from the major clinical dimensions of MS combined into a single score. Quantitative functional composites are likely to provide improved precision and sensitivity in future MS clinical trials. Studies necessary to further refine quantitative functional composites as useful MS clinical trial outcomes are delineated.

UR - http://www.scopus.com/inward/record.url?scp=0031226430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031226430&partnerID=8YFLogxK

M3 - Article

C2 - 9307263

AN - SCOPUS:0031226430

VL - 42

SP - 379

EP - 382

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 3

ER -